Skip to main content

Newsroom press releases

17/12/24 - 12:56

2025 Annual Calendar of Corporate Events (104.79 KB)
Download

11/11/24 - 7:38

Diasorin Announces 510(k) Submission for LIAISON PLEX® Gram-Positive Blood Culture Assay, to complete the Blood Culture portfolio on LIAISON PLEX® (122.52 KB)
Products Molecular
Download

05/11/24 - 16:27

Diasorin reports another quarter with Revenues and Profitability in expansion, raising the Full-Year 2024 Revenue Guidance (238.01 KB)
Financial Data
Download

27/09/24 - 7:35

Diasorin announces 510(k) submission for LIAISON PLEX® Gram-Negative Blood Culture Assay (559.45 KB)
Products Molecular
Download

09/09/24 - 13:11

Diasorin launches the LIAISON® Streptococcus pneumoniae Ag Assay in all countries accepting the CE Mark (498.13 KB)
Products Immunodiagnostic
Download

05/09/24 - 11:17

DiaSorin S.p.A. - Update 2024 Annual Calendar of Corporate Events (99.93 KB)
Other
Download

04/09/24 - 11:36

Diasorin S.p.A. - Shareholders' Meeting September 4, 2024 (136.09 KB)
Other
Download

29/07/24 - 15:55

DIASORIN RAISES FULL-YEAR 2024 GUIDANCE AS A RESULT OF THE POSITIVE PERFORMANCE OF THE FIRST SEMESTER OF THE YEAR (606.06 KB)
Financial Data
Download

16/07/24 - 8:31

Diasorin receives FDA de-novo grant for the SIMPLEXA® C. auris Direct assay on the LIAISON® MDX instrument (546.76 KB)
Products Molecular
Download

05/06/24 - 5:07

Diasorin receives FDA 510(k) clearance for the LIAISON PLEX® Blood Culture Yeast Assay on the new multiplexing LIAISON PLEX® (693.98 KB)
Products Molecular
Download

16/05/24 - 19:56

Diasorin receives FDA 510(k) clearance for the updated syndromic panel NxTAG® Respiratory Pathogen Panel v2 (500.66 KB)
Products Molecular
Download

10/05/24 - 15:21

Q1 Revenues and Adjusted EBITDA in line with the high range of the FY’24 Guidance (689.42 KB)
Financial Data
Download

24/04/24 - 15:38

Shareholders' Meeting 2024 (159.72 KB)
Other
Download

16/04/24 - 8:20

Communication on total amount of voting rights (135.47 KB)
Other
Download

15/03/24 - 13:35

The Board of Directors of Diasorin SpA approves FY2023 Results; proposed ordinary dividend of € 1.15 per share (401.32 KB)
Financial Data
Download

13/03/24 - 10:23

Diasorin submits LIAISON PLEX® Yeast Blood Culture Assay for the LIAISON PLEX® system to the U.S. FDA (530.89 KB)
Products Molecular
Download

03/03/24 - 19:32

Diasorin receives FDA 510(K) clearance for its LIAISON PLEX® system together with the LIAISON PLEX® Respiratory Panel (150.83 KB)
Products Molecular
Download

25/01/24 - 7:48

Diasorin announces that it submitted the LIAISON® LymeDetect® to the U.S. Food and Drug Administration in December 2023 (507.38 KB)
Products Immunodiagnostic
Download

22/12/10 - 1:00

2011 Financial calendar (180.28 KB)
Financial Data
Download

20/12/10 - 1:00

Dividend may be distributed in June (445.78 KB)
Financial Data
Download

02/12/10 - 1:00

Comment on position Paper on Vitamin D (53.46 KB)
Products Immunodiagnostic
Download

24/11/10 - 1:00

Change in share capital (46.85 KB)
Financial Data
Download

18/11/10 - 1:00

Financial instruments to employees (48.33 KB)
Financial Data
Download

05/11/10 - 1:00

The BoD approves Q3'10 results (414.16 KB)
Financial Data
Download

02/11/10 - 1:00

Change in share capital (313.61 KB)
Financial Data
Download

08/10/10 - 2:00

2010 Financial calendar update (174.1 KB)
Financial Data
Download

30/09/10 - 2:00

Change in share capital (5.25 KB)
Financial Data
Download

24/09/10 - 2:00

Financial instruments to employees (48.81 KB)
Financial Data
Download

16/09/10 - 2:00

Stock options exercised by key managers (195.67 KB)
Financial Data
Download

02/09/10 - 2:00

Financial instruments to employees (24.27 KB)
Financial Data
Download

06/08/10 - 2:00

The BoD approves H1'10 results (287.11 KB)
Financial Data
Download

07/07/10 - 2:00

Agreement with Meridian Inc. (182.7 KB)
Acquisition / Partnership
Download

06/07/10 - 2:00

2010 Financial calendar update (174.1 KB)
Financial Data
Download

02/07/10 - 2:00

Financial instruments to employees (24.37 KB)
Financial Data
Download

01/06/10 - 2:00

Acquisition of MUREX product line (102.6 KB)
Acquisition / Partnership
Download

14/05/10 - 2:00

The BoD approves Q1'10 results (254.05 KB)
Financial Data
Download

27/04/10 - 2:00

Approval of statutory financial statements (182.99 KB)
Financial Data
Download

20/04/10 - 2:00

2010 Financial calendar update (168.23 KB)
Financial Data
Download

14/04/10 - 2:00

Postponement of the term for lists of members of the Board of Auditors (40.34 KB)
Financial Data
Download

09/04/10 - 2:00

China approves new prenatal screening product line on LIAISON (141.08 KB)
Products Immunodiagnostic
Download

02/04/10 - 2:00

Financial instruments to employees (27.79 KB)
Financial Data
Download

22/03/10 - 1:00

The BoD approves FY 2009 results (306.02 KB)
Financial Data
Download

10/03/10 - 1:00

Acquisition of MUREX product line (45.5 KB)
Acquisition / Partnership
Download

01/03/10 - 1:00

2010 Financial calendar update (192.49 KB)
Financial Data
Download

12/02/10 - 1:00

The BoD approves Q4'09 results (213.8 KB)
Financial Data
Download

18/01/10 - 1:00

2010 Financial calendar (103 KB)
Financial Data
Download
Price Sensitive

eMarket SDIR System and eMarket STORAGE
For the dissemination and the storage of Regulated Information, DiaSorin S.p.A. uses the eMarket SDIR circuit and the eMarket STORAGE mechanism (available at the address www.emarketstorage.it), managed by Teleborsa S.r.l., with registered office in Piazza di Priscilla, 4, Rome, Italy.